|
A clinical trial for a potential treatment for COVID-19 is now underway in Edmonton and Calgary. In the trial, convalescent plasma is taken from patients who have recovered from COVID-19. That plasma, which contains antibodies to the virus, is then transferred to patients who are being hospitalized for the illness but have not yet been intubated.
|